General Dentistry News

Dentistry

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Persson U et al. – Ex ante VBP assessment is a form of risk sharing, which has been used by TLV to speed up reimbursement and dispersion of effective new drugs despite uncertainty in their true cost–effectiveness. Manufacturers are often asked in return to generate additional health economic evidence that will establish cost–effectiveness as part of ex post review. The alternative is to delay the reimbursement approval until satisfactory evidence is available.

Today in Economics of Medicine...keeping you current

Hospitals and communities continue to feel recession's impact
American Hospital Association News, 12/04/09

Perception of the economic value of primary care services: A willingness to pay study
Health Policy, 12/03/09

Rising mortality and life expectancy differentials by lifetime earnings in the United States
Journal of Health Economics, 11/24/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address